Mediators of Inflammation

Inflammation in Liver Diseases


Publishing date
15 Dec 2017
Status
Published
Submission deadline
28 Jul 2017

Lead Editor

1National Institute on Alcohol Abuse and Alcoholism, Bethesda, USA

2National Institute of Health, Bethesda, USA

3Shanghai Institutes for Biological Sciences, Shanghai, China

4Anhui Medical University, Hefei, China


Inflammation in Liver Diseases

Description

Liver is the largest solid organ in our body responsible for nutrient assimilation and protein synthesis. Recently, accumulating evidence shows that the liver is not only a major metabolic organ, but also an immunologic organ. For example, many liver-resident antigen-presenting cells modulate immune regulatory function. Kupffer cells have an important role in phagocytosis to prevent invasion of pathogenic organisms from the intestine. Innate lymphocytes, including both natural killer cells and natural killer T cells, are enriched in the liver. Liver is also the major organ that produces acute phase proteins, which are modulate inflammatory response in acute as well as chronic liver disease models.

The immune cells in the liver are critical in the pathogenesis of almost all types of liver diseases like viral hepatitis, fatty liver, alcoholic liver diseases, cirrhosis, drug/toxin induced injury, and so on. The studies on liver inflammation and its pathways will greatly improve the understanding of the mechanism of how liver immune cells which interacted with hepatocytes and other resident cells in the liver can cause liver damage. These studies will also be very helpful to develop novel therapeutics for various liver diseases.

We invite authors to contribute original research articles as well as review articles that will provide the information on the following topics.

Potential topics include but are not limited to the following:

  • Understanding of the immune and inflammatory processes responsible for the progression of the following liver diseases: alcoholic and nonalcoholic steatohepatitis, acute or chronic viral hepatitis, hepatocellular carcinoma, and drug and other hepatotoxins induced liver injury
  • Novel strategies for treating inflammatory liver diseases

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 3927134
  • - Editorial

Inflammation in Liver Diseases

Dechun Feng | Partha Mukhopadhyay | ... | Hua Wang
  • Special Issue
  • - Volume 2017
  • - Article ID 9029327
  • - Research Article

HIF1α-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages

Ting Wang | Huiying Liu | ... | Changtao Jiang
  • Special Issue
  • - Volume 2017
  • - Article ID 5605981
  • - Research Article

Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013

Binxia Chang | Baosen Li | ... | Zhengsheng Zou
  • Special Issue
  • - Volume 2017
  • - Article ID 5314213
  • - Review Article

IL-33-ST2 Axis in Liver Disease: Progression and Challenge

Zijian Sun | Binxia Chang | ... | Zhengsheng Zou
  • Special Issue
  • - Volume 2017
  • - Article ID 7960907
  • - Clinical Study

Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients

Qing Shi | Rong Shen | ... | Wei-Li Zhao
  • Special Issue
  • - Volume 2017
  • - Article ID 4256352
  • - Review Article

Liver Regeneration: Analysis of the Main Relevant Signaling Molecules

Yachao Tao | Menglan Wang | ... | Hong Tang
  • Special Issue
  • - Volume 2017
  • - Article ID 3526903
  • - Research Article

Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage

Yan Wang | Zhenzhen Zhang | ... | Guiqiang Wang
  • Special Issue
  • - Volume 2017
  • - Article ID 3480234
  • - Research Article

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease

Magdalena Świderska | Jerzy Jaroszewicz | ... | Robert Flisiak
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.